Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11827972rdf:typepubmed:Citationlld:pubmed
pubmed-article:11827972lifeskim:mentionsumls-concept:C0042666lld:lifeskim
pubmed-article:11827972lifeskim:mentionsumls-concept:C0567416lld:lifeskim
pubmed-article:11827972lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:11827972lifeskim:mentionsumls-concept:C2348445lld:lifeskim
pubmed-article:11827972lifeskim:mentionsumls-concept:C1537694lld:lifeskim
pubmed-article:11827972lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:11827972lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:11827972pubmed:issue17lld:pubmed
pubmed-article:11827972pubmed:dateCreated2002-4-22lld:pubmed
pubmed-article:11827972pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11827972pubmed:abstractTextCasL/HEF1 belongs to the p130(Cas) family. It is tyrosine-phosphorylated following beta(1) integrin and/or T cell receptor stimulation and is thus considered to be important for immunological reactions. CasL has several structural motifs such as an SH3 domain and a substrate domain and interacts with many molecules through these motifs. To obtain more insights on the CasL-mediated signal transduction, we sought proteins that interact with the CasL SH3 domain by far Western screening, and we identified a novel human molecule, MICAL (a Molecule Interacting with CasL). MICAL is a protein of 118 kDa and is expressed in the thymus, lung, spleen, kidney, testis, and hematopoietic cells. MICAL has a calponin homology domain, a LIM domain, a putative leucine zipper motif, and a proline-rich PPKPP sequence. MICAL associates with CasL through this PPKPP sequence. MICAL is a cytoplasmic protein and colocalizes with CasL at the perinuclear area. Through the COOH-terminal region, MICAL also associates with vimentin that is a major component of intermediate filaments. Immunostaining revealed that MICAL localizes along with vimentin intermediate filaments. These results suggest that MICAL may be a cytoskeletal regulator that connects CasL to intermediate filaments.lld:pubmed
pubmed-article:11827972pubmed:languageenglld:pubmed
pubmed-article:11827972pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11827972pubmed:citationSubsetIMlld:pubmed
pubmed-article:11827972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11827972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11827972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11827972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11827972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11827972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11827972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11827972pubmed:statusMEDLINElld:pubmed
pubmed-article:11827972pubmed:monthAprlld:pubmed
pubmed-article:11827972pubmed:issn0021-9258lld:pubmed
pubmed-article:11827972pubmed:authorpubmed-author:MorimotoChika...lld:pubmed
pubmed-article:11827972pubmed:authorpubmed-author:OgawaSeishiSlld:pubmed
pubmed-article:11827972pubmed:authorpubmed-author:HiraiHisamaru...lld:pubmed
pubmed-article:11827972pubmed:authorpubmed-author:SuzukiTakahir...lld:pubmed
pubmed-article:11827972pubmed:authorpubmed-author:MatsumuraTomo...lld:pubmed
pubmed-article:11827972pubmed:authorpubmed-author:NakamotoTetsu...lld:pubmed
pubmed-article:11827972pubmed:authorpubmed-author:SeoSachikoSlld:pubmed
pubmed-article:11827972pubmed:authorpubmed-author:TachibanaKoui...lld:pubmed
pubmed-article:11827972pubmed:issnTypePrintlld:pubmed
pubmed-article:11827972pubmed:day26lld:pubmed
pubmed-article:11827972pubmed:volume277lld:pubmed
pubmed-article:11827972pubmed:ownerNLMlld:pubmed
pubmed-article:11827972pubmed:authorsCompleteYlld:pubmed
pubmed-article:11827972pubmed:pagination14933-41lld:pubmed
pubmed-article:11827972pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:meshHeadingpubmed-meshheading:11827972...lld:pubmed
pubmed-article:11827972pubmed:year2002lld:pubmed
pubmed-article:11827972pubmed:articleTitleMICAL, a novel CasL interacting molecule, associates with vimentin.lld:pubmed
pubmed-article:11827972pubmed:affiliationDepartment of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.lld:pubmed
pubmed-article:11827972pubmed:publicationTypeJournal Articlelld:pubmed
http://bio2rdf.org/pubmed:1...skos:relatedMatchpubmed-article:11827972lld:mappings
entrez-gene:2885entrezgene:pubmedpubmed-article:11827972lld:entrezgene
entrez-gene:6714entrezgene:pubmedpubmed-article:11827972lld:entrezgene
entrez-gene:7431entrezgene:pubmedpubmed-article:11827972lld:entrezgene
entrez-gene:25entrezgene:pubmedpubmed-article:11827972lld:entrezgene
entrez-gene:1398entrezgene:pubmedpubmed-article:11827972lld:entrezgene
entrez-gene:4739entrezgene:pubmedpubmed-article:11827972lld:entrezgene
entrez-gene:64780entrezgene:pubmedpubmed-article:11827972lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11827972lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11827972lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11827972lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11827972lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11827972lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11827972lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11827972lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11827972lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11827972lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11827972lld:pubmed